A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine

Transplantation

Volumn 65, Issue 9, 1998, Pages 1197-1202

  Jurcevic, Stipo ^a   Dunn, Michael J ^a   Crisp, Samantha ^a   Busing, Karen ^a   Rinaldi, Mauro ^b   Pellegrini, Carlo ^b   Yacoub, Magdi H ^a   Vigano, Mario ^b   Banner, Nicholas L ^a   Rose, Marlene L ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PROTEIN ANTIBODY; STEROID; TACROLIMUS; VIMENTIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL;

ANTIBODIES; BLOTTING, WESTERN; CORONARY DISEASE; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TACROLIMUS; VIMENTIN;

EID: 0032525064     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805150-00010     Document Type: Article

References (31)

1. Bieber C, Stinson E, Shumway N, Payne R, Kosek J. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation 1970; 41: 753.
2. Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated cornary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation 1989; 80 (suppl III): 100.
3. Tullius SG, Tilney NL. Both alloantigen-dependent and independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
4. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments and future directions. J Heart Lung Transplant 1992; 11: 9.
5. Suciu-Foca NE, Reed C, Marboe C, et al. The role of anti-HLA antibodies in heart transplantation. Transplantation 1991; 51: 716.
6. Reed E, Hong B, Ho E, Harris P, Weinberger J, Suci-Foca N. Monitoring of soluble HLA alloantigens and antiHLA antibodies identifies heart allograft recipients at risk of transplant asociated coronary artery disease. Transplantation 1996; 61: 566.
7. Page CS, Rose ML, Yacoub MH, Piggot R. Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992; 141: 673.
8. Taylor PM, Rose ML, Yacoub MH. Coronary artery immungenecity: a comparison between explanted and recipient or donor and transplanted hearts. Transplant Immunol 1993; 1: 294.
9. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Antiendothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 566.
10. Crisp SJ, Dunn MJ, Rose ML, Barbir M, Yacoub MH. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant associated coronary artery disease. J Heart Lung Transplant 1994; 13: 81.
11. Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, Rose ML. Characterisation of endothelial antigens associated with transplant associated coronary artery disease. J Heart Lung Transplant 1995; 14: S188.
12. Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis 1996; 28: 159.
13. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridisation. Proc Natl Acad Sci USA 1983; 80: 3734.
14. Bradford MB A rapid and sensitive method for the quantitation of microgram quantitites of protein utilising the principle of dye-binding. Anal Biochem 1976; 72: 248.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680.
16. Latif N, Rose ML, Yacoub MH, Dunn MJ. Association of pretransplantation antiheart antibodies with clinical course after heart transplantation. J Heart Lung Transplant 1995; 14: 119.
17. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587.
18. Smith JD, Danskine AJ, Rose ML, Yacoub MH. Specificity of lymphocytotxic antibodies formed after cardiac transplantation and correlation with rejection episodes. Transplantation 1992; 53: 1358.
19. Martin S, Dyer P, Mallick N, Gokal R, Harris R, Johnson R. Posttranplant antidonor lymphocytotxic antibody production and relation to graft outcome. Transplantation 1987; 44: 50.
20. Rose ML. Role of antibody and indirect antigen presentation in transplant associated coronary artery vasculopathy. J Heart Lung Transplant 1996; 5: 342.
21. Ferry BL, Welsh KI, Dunn MJ, et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transplant Immunol 1997; 5: 17.
22. Al Hussein KA, Talbot D, Proud G, Taylor RMR, Shenton BK. The clinical significance of post-transplantation non-HLA antibodies in renal transplantation. Transplant Int 1995; 8: 214.
23. Johnson JA, Kobashigawa JA. Quantitative analysis of transplant coronary artery disease with use of intracoronary ultrasound. J Heart Lung Transplant 1995; 14: S198.
24. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T lymphocyte activation. Nature 1992; 357: 695.
25. Hornick P, Smith J, Pomerance A, et al. Influence of acute rejection episodes, HLA matching and donor/recipient phenotype on the development of "early" transplant coronary artery disease. Circulation (in press).
26. Walliser P, Benzie CR, Kay JE. Inhibition of murine B lymphocyte proliferation by the novel immunosuppressive drug FK-506. Immunology 1989; 68: 434.
27. Khanna A, Li B, Stenzl KH, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor β-dependent mechanism of inhibition of cell growth. Transplantation 1994; 57: 577.
28. Hutchinson IV. Mode of action of immunosuppressive agents. In: Hakim NS, ed. Current immunosuppression: an update. Round Table Series 49. London: Royal Society of Medicine Press Ltd., 1997: 25.
29. Williams R., Neuhaus P, Bismuth H, et al. Two year data from the European multicetre tacrolimus (FK506) liver study. Transplant Int 1996; 9: S144.
30. Armitage JM, Kormos RL, Fung J et al. Preliminary experience with FK506 in thoracic transplantation. Transplantation 1991; 52: 164.
31. Reichart B, Meiser B, Vigano M, et al. Tacrolimus (FK506) vs. cyclosporine in heart transplantation: results from a randomised, European, multicentre pilot study [Abstract]. London: Seventeenth Annual Meeting of ISHLT, 1997.